P829: a phase iii randomized clinical trial comparing sb12 (proposed eculizumab biosimilar) with reference eculizumab in patients with paroxysmal nocturnal hemoglobinuria
HemaSphere（2022）
关键词
proposed eculizumab biosimilar,reference eculizumab,paroxysmal nocturnal
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要